Radiation Therapy and Dosimetry
Radiation Therapy and Dosimetry is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 36k research works in it since 1950. 18.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the advancements in particle therapy for cancer treatment, focusing on the use of proton therapy, gold nanoparticles for radiation sensitization, Monte Carlo simulations to address range uncertainties, and the biological effectiveness of different radiation modalities. It also delves into the implications of space radiation and the potential clinical applications of these developments.
- Particle Therapy
- Proton Therapy
- Gold Nanoparticles
- Radiation Sensitization
- Monte Carlo Simulations
- Biological Effectiveness
- Space Radiation
- Nanoparticle Radiosensitization
- Range Uncertainties
- Clinical Applications
- Research works
- 36k fractional, since 1950
- In the world top 10%
- 6.6k per year above
- Top-10% rate
- 18.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +3% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Radiation Therapy and Dosimetry research?
By volume, the United States and China publish the most (1.1k and 589 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 China 589 works
- 3 Japan 415 works
- 4 Germany 304 works
- 5 Italy 268 works
- 6 France 200 works
- 7 India 198 works
- 8 Russia 176 works
- 9 United Kingdom 174 works
- 10 Canada 142 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Radiation Therapy and Dosimetry research?
By volume in 2022–2025, National Institutes for Quantum Science and Technology publishes the most Radiation Therapy and Dosimetry research, followed by The University of Texas MD Anderson Cancer Center and Chinese Academy of Sciences.
By volume, 2022–2025
- 1 National Institutes for Quantum Science and TechnologyJapan 43 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 36 works
- 3 Chinese Academy of SciencesChina 26 works
- 4 European Organization for Nuclear ResearchSwitzerland 26 works
- 5 Memorial Sloan Kettering Cancer CenterUnited States 22 works
- 6 Heidelberg UniversityGermany 21 works
- 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 8 Mayo Clinic in FloridaUnited States 19 works
- 9 GSI Helmholtz Centre for Heavy Ion ResearchGermany 19 works
- 10 Paul Scherrer InstituteSwitzerland 19 works
Who are the leading researchers in Radiation Therapy and Dosimetry?
The most-cited researchers publishing on Radiation Therapy and Dosimetry include X. Wu, H. F-W. Sadrozinski and Y. Makida.
- 1 X. Wu Switzerland 9.6k citations
- 2 H. F-W. Sadrozinski United States 9.1k citations
- 3 Y. Makida Japan 8.1k citations
- 4 G. N. Taylor Australia 7.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Radiation Therapy and Dosimetry research done?
The largest centres of Radiation Therapy and Dosimetry research in 2022–2025 are Beijing (China), Moscow (Russia), Heidelberg (Germany) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Chiba.
Largest cities, 2022–2025
Where it is the local speciality
- ChibaJP · 48.7 works20×
Location quotient: how much more of its research is in Radiation Therapy and Dosimetry than the world average.
Where is the best place to study Radiation Therapy and Dosimetry?
Among universities, judged by research, Heidelberg University, ETH Zurich and University of Wollongong score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Heidelberg UniversityGermany | 54.8 | 24.8% | 7.8× | 21 | -8.6% |
| 2 | ETH ZurichSwitzerland | 50.5 | 43.1% | 2.5× | 9 | +76.2% |
| 3 | University of WollongongAustralia | 49.5 | 21.9% | 8.2× | 11 | +27.1% |
| 4 | National Research Nuclear University MEPhIRussia | 46.4 | 5.1% | 17.8× | 11 | +197.2% |
| 5 | Homi Bhabha National InstituteIndia | 44.6 | 11.8% | 12.3× | 13 | — |
| 6 | Ludwig-Maximilians-Universität MünchenGermany | 44.1 | 24.3% | 3.6× | 12 | +134.3% |
| 7 | University of BernSwitzerland | 42.3 | 34.9% | 4.0× | 8 | -6.0% |
| 8 | University of Maryland, BaltimoreUnited States | 42.0 | 14.0% | 7.7× | 12 | +84.5% |
| 9 | Gunma UniversityJapan | 41.3 | 12.8% | 17.4× | 9 | +80.2% |
| 10 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 40.3 | 17.6% | 4.2× | 20 | +82.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Radiation Therapy and Dosimetry research growing?
Output in 2018–2022 was 3% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Radiation Therapy and Dosimetry.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.